Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander C Ford

Showing results (161-170 of 451) with videos related to

Pageof 46
Sort By:
Gut|August 11, 2021
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysisChristopher J Black, Heidi M Staudacher, Alexander C Ford
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Pathophysiology of irritable bowel syndromeGerald J Holtmann, Alexander C Ford, Nicholas J Talley
Gastroenterology|September 7, 2005
Image of the month. Autoimmune pancreatitisAlexander C Ford, Alan G Chalmers, P John Hamlin
Gastroenterology|November 21, 2020
In the Face of Adversity: Is Resilience a New Target for Inflammatory Bowel Disease Therapy?Keeley M Fairbrass, David J Gracie, Alexander C Ford
The American Journal of Gastroenterology|February 18, 2018
Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel diseaseDavid J Gracie, John P Hamlin, Alexander C Ford
The American Journal of Gastroenterology|November 2, 2020
Efficacy of Senna and Magnesium Oxide for the Treatment of Chronic Idiopathic ConstipationVivek C Goodoory, Christopher J Black, Alexander C Ford
The American Journal of Gastroenterology|June 12, 2013
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysisAlexander C Ford, Darren M Brenner, Philip S Schoenfeld
Gastroenterology|May 20, 2023
ReplyMaria Rosa Ingrosso, Christopher J Black, Alexander C Ford
BMJ (Clinical Research Ed.)|May 1, 2024
Irritable bowel syndrome: low dose antidepressant improves symptomsHelen Saul, Samantha Cassidy, Laura Swaithes, et al.
The American Journal of Gastroenterology|January 8, 2011
Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndromeMichael B Sprakes, P John Hamlin, Alexander C Ford
Pageof 46

Showing results (161-170 of 451) with videos related to

Sort By:
Pageof 46
Gut|August 11, 2021
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysisChristopher J Black, Heidi M Staudacher, Alexander C Ford
The Lancet. Gastroenterology & Hepatology|April 14, 2017
Pathophysiology of irritable bowel syndromeGerald J Holtmann, Alexander C Ford, Nicholas J Talley
Gastroenterology|September 7, 2005
Image of the month. Autoimmune pancreatitisAlexander C Ford, Alan G Chalmers, P John Hamlin
Gastroenterology|November 21, 2020
In the Face of Adversity: Is Resilience a New Target for Inflammatory Bowel Disease Therapy?Keeley M Fairbrass, David J Gracie, Alexander C Ford
The American Journal of Gastroenterology|February 18, 2018
Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel diseaseDavid J Gracie, John P Hamlin, Alexander C Ford
The American Journal of Gastroenterology|November 2, 2020
Efficacy of Senna and Magnesium Oxide for the Treatment of Chronic Idiopathic ConstipationVivek C Goodoory, Christopher J Black, Alexander C Ford
The American Journal of Gastroenterology|June 12, 2013
Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysisAlexander C Ford, Darren M Brenner, Philip S Schoenfeld
Gastroenterology|May 20, 2023
ReplyMaria Rosa Ingrosso, Christopher J Black, Alexander C Ford
BMJ (Clinical Research Ed.)|May 1, 2024
Irritable bowel syndrome: low dose antidepressant improves symptomsHelen Saul, Samantha Cassidy, Laura Swaithes, et al.
The American Journal of Gastroenterology|January 8, 2011
Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndromeMichael B Sprakes, P John Hamlin, Alexander C Ford
Pageof 46